Xencor (XNCR) Non-Current Assets (2013 - 2026)

Xencor (XNCR) reported Non-Current Assets of $254.0 million for Q1 2026, down 33.76% year-over-year from $383.4 million in Q1 2025, and down 7.87% quarter-over-quarter from $275.7 million in Q4 2025.

Xencor (XNCR) Non-Current Assets (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Non-Current Assets data on file, last reported at $254.0 million in Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $254.0 million, down 33.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 13.44% YoY), and the FY2025 annual result was $275.7 million, down 26.36% from the prior year.
  • Non-Current Assets declined to $254.0 million in Q1 2026 per XNCR's latest filing, from $275.7 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $410.3 million in Q3 2024 and troughed at $167.3 million in Q3 2022.
  • A 5-year average of $285.8 million and a median of $275.7 million in 2025 frame the typical range for Non-Current Assets.
  • On a YoY basis, Non-Current Assets climbed as much as 246.52% in 2022 and fell as far as 58.7% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $170.9 million in 2022, then jumped by 92.79% to $329.5 million in 2023, then climbed by 13.6% to $374.3 million in 2024, then dropped by 26.36% to $275.7 million in 2025, then slipped by 7.87% to $254.0 million in 2026.
  • Business Quant data shows XNCR's Non-Current Assets at $254.0 million in Q1 2026, $275.7 million in Q4 2025, and $350.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Xencor 953.38 Mn 878.64 Mn - 253.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 253.99 Mn
Dec 31, 2025 275.67 Mn
Sep 30, 2025 350.37 Mn
Jun 30, 2025 366.27 Mn
Mar 31, 2025 383.42 Mn
Dec 31, 2024 374.34 Mn
Sep 30, 2024 410.31 Mn
Jun 30, 2024 271.70 Mn
Mar 31, 2024 322.00 Mn
Dec 31, 2023 329.53 Mn
Sep 30, 2023 207.25 Mn
Jun 30, 2023 184.56 Mn
Mar 31, 2023 173.44 Mn
Dec 31, 2022 170.92 Mn
Sep 30, 2022 167.27 Mn
Jun 30, 2022 265.39 Mn
Mar 31, 2022 351.95 Mn
Dec 31, 2021 413.84 Mn
Sep 30, 2021 367.64 Mn
Jun 30, 2021 214.64 Mn